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This special issue of Palliative Medicine considers different approaches to palliative care evaluation. 
It has its origin in a meeting organised in 2010 by the Capacity Building and Methodology Themes of 
the Cancer Experiences Collaborative (see next editorial), in light of an increasing recognition that 
the traditional randomised controlled trial (RCT) design does not always provide the best approach 
to much needed evaluation in palliative care.  
 
There is a clear need to subject palliative care to comprehensive and robust evaluation to improve 
the evidence base for palliative care provision1. The RCT remains the gold standard for establishing 
the efficacy and effectiveness of interventions. However, there is a considerable lack of RCTs in 
palliative care, in particular traditional RCT designs, i.e. where individual patients are randomised to 
treatment or control conditions. Where such trials are reported, they may often provide inconclusive 
evidence due to challenges associated with conducting trials in palliative care2. At worst, adopting a 
research design that cannot be successfully implemented may appear to undermine palliative care 
by failing to show any significant benefits of such care, at best it represents a considerable use of 
time and resources in return for limited results.  
 
We therefore need to take stock to ensure we use the best possible but feasible methods in our 
repertoire for evaluation. In doing so we must not forget why the principles of the original RCT 
design are important in obtaining robust evidence for effectiveness, and retain these where 
possible.   
 
Part of the problem in evaluating palliative care is that we are almost always dealing with a complex 
intervention. Complex interventions are interventions containing several interacting components, 
and their complexity may e.g. relate to the complexity, number, and flexibility of the components of 
the intervention itself and/or the groups, organisational levels and outcomes targeted3.  
 
There is increasing recognition, not just within palliative care, that the evaluation of complex 
interventions requires a departure from the approach adopted in drugs trials from which RCTs 
originated. The MRC Framework for Development and Evaluation of RCTs for Complex Interventions 
to Improve Health4 recognised the need for a better understanding of the intervention and its 
components, the barriers to its implementation, the process of evaluation itself, the potential range 
of outcomes and the role for qualitative research alongside quantitative methods. Nevertheless, it 
was still based on the linear model of drugs trials and firmly focused on RCTs.  
 
The MRC New Guidance3 on evaluation of complex interventions (having dropped reference to RCTs 
in its title) has evolved to give greater coverage of non-experimental methods, and distances itself 
more from the drug trials model and the assumption that clinical trials provide the template for all 
approaches to evaluation. It also to a greater extent recognises the constraints on researchers’ 
choice of intervention and evaluation methods; that often researchers will have no influence over 
the development of the intervention or its implementation; and that ethics or political context may 
prevent randomisation or withholding of the intervention. It notes that “given the cost of such 
interventions, evaluation should still be considered: ‘best available’ methods, even if they are not 
theoretically optimum, may yield useful results”3 (p 8).  
 
Palliative care research shares all the challenges associated with evaluation of complex 
interventions. It has further challenges associated with research on palliative care patients that may 
make evaluation harder, including ethical and emotional concerns over manipulating interventions 
(or even ‘questioning’ their value), as well as pragmatic problems of recruitment, attrition, data 
collection and missing data. An MRC Methods Research Programme project led by Irene Higginson, 
Kings College London, is underway to establish specific guidelines for research within palliative care 
building on the MRC Guidance, although it should be recognised that the difference in challenges 
faced by palliative care researchers is a matter of degree rather than being a class apart.   
 
Topics of papers included in this Special Issue 
 
Despite the challenges, we should obtain the best evidence we can and aim for well designed RCTs 
where possible. Traditional RCT design with individually randomised patients can be made to work in 
palliative care in some circumstances5. However, ethical concerns over withholding potentially 
beneficial interventions from dying patients or delaying interventions for those with limited life 
span, as in waiting list RCT designs, may present a barrier to such trials. An acceptable alternative 
may be Fast Track RCTs, where randomisation can lead to faster access to the intervention, as 
explained in the paper by Higginson in this issue.  
 Randomisation of individuals, even if it leads to faster intervention, may still raise considerable 
ethical and pragmatic concerns. Cluster RCT designs, where ‘clusters’ rather than patients are 
randomised and all patients within a ‘cluster’ (e.g. a GP practice, hospice home care team) receive 
the same care, may prove more feasible and acceptable, in part because this situation is similar to 
the local variations in care often experienced due to differential service implementation in different 
areas. Nevertheless, cluster RCTs present their own challenges, and Ian Russell considers the pros 
and cons of such designs in a second paper in this issue. 
 
Regardless of trial design the challenges of palliative care research mean that we may need to work 
even harder than other disciplines to make our research protocols viable. The paper by Audrey 
considers the essential role of qualitative research in aiding the development and conduct of trials, 
also reflected in the emphasis MRC guidance places on such work in the preparation and process of 
trials3 4.  
 
Nevertheless, in many cases RCTs are not feasible, particularly where researchers have no control 
over the intervention. The End of Life Care Strategy1 for England recognises the need to develop 
methods that can evaluate the natural experiments that arise from service re-design. Here we need 
to evaluate through the best methods possible for the situation.  While not optimum, non-
experimental methods such as well-conducted before-after studies can yield useful results, although 
the possible biases inherent in such methods must be considered 3. Costantini considers how such 
designs may represent an evaluation in their own right or form the preparatory work future trials.  
 
It is of limited use to establish whether an intervention appears to work or not, however robust our 
method, if we do not know why it works, what aspects of the intervention or its context make it 
work, and how it may be translated to other contexts3 4. Addington-Hall’s paper highlights the value 
of mixed-methods approaches where insights gained from qualitative and quantitative approaches 
complement each other to provide a more in-depth understanding of the intervention evaluated. 
  
The MRC New Guidance3 also highlights the need to understand the context in which an intervention 
works, the interlinking processes taking place and the intervention’s impact at different levels, i.e. 
the broader system. Furthermore, in some cases the intervention itself may be considered a 
complex system or be aimed at changing complex systems6. In such circumstances case study 
approaches may offer useful avenues for evaluation, and Walshe’s paper discusses when and where 
such methods may be fruitfully applied. 
 
Taking this a step further, we need to recognise that complex interventions are not immutable, they 
will often themselves be influenced by their broader political, cultural and organisational context.  
The relevant actors and their interaction with an intervention will affect and shape both the 
intervention itself and its outcomes. An understanding of such processes and their relation to 
successful implementation is likely to make important contributions to palliative care evaluation. 
The paper by Froggatt and Hockey considers how participatory action research may offer valuable 
insights in this context. 
 
Clearly there are other approaches to evaluation that we have been unable to include in this issue, 
ranging from variants on the RCT design to systems approaches that involve broader sociological or 
economic perspectives and larger datasets. However, in general we need to be aware of the broader 
repertoire of methods at our disposal and select the best method or methods available for each 
situation and question. Furthermore, we are unlikely to have all the relevant questions answered by 
one method or any one study. It is therefore important to be conscious of how each study will 
contribute to a larger process of evaluation, whether we use the framework laid out by the MRC to 
guide this or some other framework. We must stop conducting isolated pieces of palliative care 
research.     
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